Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outset Medical (OM) Cash from Financing Activities (2019 - 2025)

Outset Medical (OM) has disclosed Cash from Financing Activities for 7 consecutive years, with $231000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Cash from Financing Activities rose 90.91% to $231000.0 in Q3 2025 year-over-year; TTM through Dec 2025 was $55.5 million, a 18.22% decrease, with the full-year FY2025 number at $55.5 million, down 18.22% from a year prior.
  • Cash from Financing Activities was $231000.0 for Q3 2025 at Outset Medical, up from -$384000.0 in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $150.8 million in Q2 2021 to a low of -$938000.0 in Q4 2024.
  • A 5-year average of $21.1 million and a median of $2.5 million in 2022 define the central range for Cash from Financing Activities.
  • Peak YoY movement for Cash from Financing Activities: soared 558448.15% in 2021, then crashed 598.7% in 2025.
  • Outset Medical's Cash from Financing Activities stood at $934000.0 in 2021, then soared by 6923.55% to $65.6 million in 2022, then crashed by 49.35% to $33.2 million in 2023, then crashed by 102.82% to -$938000.0 in 2024, then skyrocketed by 124.63% to $231000.0 in 2025.
  • Per Business Quant, the three most recent readings for OM's Cash from Financing Activities are $231000.0 (Q3 2025), -$384000.0 (Q2 2025), and $55.7 million (Q1 2025).